Investments (#)
Investments (USD)
Transactions
Recent transactions in the domain of antibody development
| Company | Country | Funding round | Date | |
|---|---|---|---|---|
|
AxiomX Inc Next-generation antibody development platform. |
United States | Acquisition |
1 Nov 2015 |
|
Memo Therapeutics AG |
Switzerland | N/A |
|
|
|
Memo Therapeutics AG |
Switzerland | N/A |
|
|
|
Memo Therapeutics AG |
Switzerland | N/A |
|
|
|
Memo Therapeutics AG |
Switzerland | N/A |
Companies
Best funded companies in antibody development
Investors
Top investors in the domain of antibody development
| Investor | Profile | Country | Investments | |
|---|---|---|---|---|
|
Verve Capital Partners AG | Switzerland | 1 | |
|
Redalpine Venture Partners AG | Seed and early-stage venture capital firm investing in disruptive technologies with focus on highly scalable ICT and Health Tech models. | Switzerland | 1 |
|
Vital Venture Capital | United States | 1 | |
|
Zurich Cantonal Bank | Switzerland | 1 | |
|
Schroder Adveq Management AG | 1 |
Acquirers
Top acquirers in the domain of antibody development
| Investor | Profile | Country | Acquisitions | |
|---|---|---|---|---|
|
Abcam PLC | Abcam plc is a producer and distributor of research-grade antibodies and associated products. | United States | 1 |